Rxcurve
HCPCS J7186 · per PER FACTOR VIII IU

Antihemophilic viii/vwf comp

Products billed under this code include Alphanate.

Payment limit per PER FACTOR VIII IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J7186

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Alphanate Grifols USA, LLC 68516-4616-01 1 $1.267
Alphanate Grifols USA, LLC 68516-4617-01 1 $1.267
Alphanate Grifols USA, LLC 68516-4618-02 1 $1.267
Alphanate Grifols USA, LLC 68516-4619-02 1 $1.267
Alphanate Grifols USA, LLC 68516-4620-02 1 $1.267

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $1.267 −$0.002 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted September 17, 2026
3Q26 $1.269 +$0.017 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted September 15, 2026
2Q26 $1.252 +$0.011 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted September 15, 2026
1Q26 $1.241 −$0.004 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted September 15, 2026
4Q25 $1.245 +$0.018 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted September 8, 2026
3Q25 $1.227 +$0.029 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted March 10, 2026
2Q25 $1.198 −$0.001 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted March 10, 2026
1Q25 $1.199 −$0.026 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted December 19, 2025
4Q24 $1.225 +$0.035 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 11, 2025
3Q24 $1.19 +$0.004 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 11, 2025
2Q24 $1.186 −$0.016 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted March 11, 2025
1Q24 $1.202 −$0.016 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted December 19, 2024
4Q23 $1.218 +$0.002 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted October 10, 2024
3Q23 $1.216 +$0.045 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 5, 2024
2Q23 $1.171 +$0.008 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted February 23, 2024
1Q23 $1.163 +$0.015 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted December 6, 2023
4Q22 $1.148 +$0.008 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 22, 2023
3Q22 $1.14 −$0.011 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 9, 2023
2Q22 $1.151 +$0.019 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted December 14, 2022
1Q22 $1.132 −$0.003 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 8, 2022
4Q21 $1.135 +$0.014 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 2, 2022
3Q21 $1.121 +$0.005 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted June 2, 2022
2Q21 $1.116 −$0.007 PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted March 1, 2022
1Q21 $1.123 – PER FACTOR VIII IU Antihemophilic viii/vwf comp v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files